Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Qps Mra, Llc
2722
mi
from 98109
Hollywood, FL
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Qps Mra, Llc
2722
mi
from 98109
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Multi-Specialty Research Associates, Inc
2411
mi
from 98109
Lake City, FL
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Multi-Specialty Research Associates, Inc
2411
mi
from 98109
Lake City, FL
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
QPS MRA
2730
mi
from 98109
Miami, FL
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
QPS MRA
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Advanced Pharma CR, LLC
2724
mi
from 98109
Miami, FL
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Advanced Pharma CR, LLC
2724
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
2547
mi
from 98109
Orlando, FL
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
2547
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Ormond Medical Arts Pharmaceutical Research
2527
mi
from 98109
Ormond Beach, FL
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Ormond Medical Arts Pharmaceutical Research
2527
mi
from 98109
Ormond Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research, LLC
2404
mi
from 98109
Savannah, GA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research, LLC
2404
mi
from 98109
Savannah, GA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research
2098
mi
from 98109
New Orleans, LA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research
2098
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
2485
mi
from 98109
Boston, MA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Milford Emergency Associates, Inc.
2469
mi
from 98109
Marlborough, MA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Milford Emergency Associates, Inc.
2469
mi
from 98109
Marlborough, MA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Michigan Head Pain & Neurological Institute
1903
mi
from 98109
Ann Arbor, MI
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Michigan Head Pain & Neurological Institute
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc.
1391
mi
from 98109
Minneapolis, MN
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc.
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
The Center for Pharmaceutical Research, P.C.
1507
mi
from 98109
Kansas City, MO
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
The Center for Pharmaceutical Research, P.C.
1507
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Sundance Clinical Research, LLC
1706
mi
from 98109
Saint Louis, MO
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Sundance Clinical Research, LLC
1706
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research Norfolk
1273
mi
from 98109
Norfolk, NE
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research Norfolk
1273
mi
from 98109
Norfolk, NE
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research
1360
mi
from 98109
Omaha, NE
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research
1360
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consortium Las Vegas
879
mi
from 98109
Las Vegas, NV
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consortium Las Vegas
879
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
2389
mi
from 98109
Berlin, NJ
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
2389
mi
from 98109
Berlin, NJ
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
SPRI Clinical Trials LLC
2407
mi
from 98109
Brooklyn, NY
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
SPRI Clinical Trials LLC
2407
mi
from 98109
Brooklyn, NY
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Regional Clinical Research, Inc.
2264
mi
from 98109
Endwell, NY
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Regional Clinical Research, Inc.
2264
mi
from 98109
Endwell, NY
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Central New York Clinical Research
2240
mi
from 98109
Manlius, NY
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Central New York Clinical Research
2240
mi
from 98109
Manlius, NY
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Fieve Clinical Research
2401
mi
from 98109
New York, NY
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Fieve Clinical Research
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
2160
mi
from 98109
Rochester, NY
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
2160
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmquest
2295
mi
from 98109
Greensboro, NC
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmquest
2295
mi
from 98109
Greensboro, NC
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
CTI Clinical Research Center
1971
mi
from 98109
Cincinnati, OH
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
CTI Clinical Research Center
1971
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Oregon Center for Clinical Investigations, Inc.
146
mi
from 98109
Portland, OR
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Oregon Center for Clinical Investigations, Inc.
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Philadelphia LLC
2377
mi
from 98109
Philadelphia, PA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Philadelphia LLC
2377
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Preferred Primary Care Physicians
2163
mi
from 98109
Uniontown, PA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Preferred Primary Care Physicians
2163
mi
from 98109
Uniontown, PA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
2486
mi
from 98109
Warwick, RI
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
2486
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
2425
mi
from 98109
Mount Pleasant, SC
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
2425
mi
from 98109
Mount Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research
1304
mi
from 98109
Dakota Dunes, SD
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research
1304
mi
from 98109
Dakota Dunes, SD
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Neurology, LP
1770
mi
from 98109
Austin, TX
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology, LP
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Neurology, LP
1676
mi
from 98109
Dallas, TX
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology, LP
1676
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Texas Center for Drug Development, P.A.
1890
mi
from 98109
Houston, TX
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
J.Lewis Research Inc / Foothill Family Clinic South
711
mi
from 98109
Salt Lake City, UT
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
J.Lewis Research Inc / Foothill Family Clinic South
711
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
J.Lewis Research Inc. / Jordan River Family Med
709
mi
from 98109
South Jordan, UT
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
J.Lewis Research Inc. / Jordan River Family Med
709
mi
from 98109
South Jordan, UT
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Associates of Tidewater
2429
mi
from 98109
Norfolk, VA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates of Tidewater
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Tidewater Integrated Medical Research
2443
mi
from 98109
Virginia Beach, VA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Tidewater Integrated Medical Research
2443
mi
from 98109
Virginia Beach, VA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
9
mi
from 98109
Bellevue, WA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
9
mi
from 98109
Bellevue, WA
Click here to add this to my saved trials
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Seattle Women's Health, Research and Gynecology
2
mi
from 98109
Seattle, WA
Safety and Efficacy Study in Adult Subjects With Acute Migraines
BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Seattle Women's Health, Research and Gynecology
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Effects of Karate in Adolescents With Down Syndrome
The Effects of Participation in Karate on Health Outcomes in Adolescents With Down Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Effects of Karate in Adolescents With Down Syndrome
The Effects of Participation in Karate on Health Outcomes in Adolescents With Down Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
University of South Florida Health
2523
mi
from 98109
Tampa, FL
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
University of South Florida Health
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
University of Vermont Medical Center
2326
mi
from 98109
Burlington, VT
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
University of Vermont Medical Center
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
Honor Health Research Institute
1112
mi
from 98109
Scottsdale, AZ
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
Honor Health Research Institute
1112
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
Indiana University Neuroscience Center
1867
mi
from 98109
Indianapolis, IN
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
Indiana University Neuroscience Center
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
2329
mi
from 98109
Baltimore, MD
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
2274
mi
from 98109
Winston-Salem, NC
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
2274
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
2294
mi
from 98109
Hershey, PA
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
2294
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials